Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The human microbiota: a new direction in the investigation of thoracic diseases.

Literature DB >> 23977433

The human microbiota: a new direction in the investigation of thoracic diseases.

Anselm Wang-Hei Hui¹, Hon-Wai Lau, Tiffany Hoi-Tung Chan, Stephen Kwok-Wing Tsui.

Abstract

Advancements in next generation sequencing technology have provided means for the comprehensive profiling of the microbial community in the respiratory tract in both physiological and pathological conditions. Recent studies have analyzed the bacterial composition in the respiratory tract of chronic obstructive pulmonary disease (COPD), influenza and tuberculosis patients, and have identified novel targets that may potentially lead to secondary infections. Certain bacteria have also been found to regulate the lung immune system and have unexpected connections with respiratory diseases. Further studies in these areas are necessary to dissect the exact relationship between the dynamics of the microbiota and the health of the respiratory system.

Entities: Disease Species

Keywords: Human microbiota; chronic obstructive pulmonary disease (COPD); influenza; next generation sequencing; thoracic diseases; tuberculosis

Year: 2013 PMID： 23977433 PMCID： PMC3747530 DOI： 10.3978/j.issn.2072-1439.2013.07.41

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

38 in total

1. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.

Authors: F Armougom; F Bittar; N Stremler; J-M Rolain; C Robert; J-C Dubus; J Sarles; D Raoult; B La Scola
Journal: Eur J Clin Microbiol Infect Dis Date: 2009-05-16 Impact factor: 3.267

2. Diagnosing bacterial respiratory infection by bronchoalveolar lavage.

Authors: F W Kahn; J M Jones
Journal: J Infect Dis Date: 1987-05 Impact factor: 5.226

3. The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics.

Authors: G Dubourg; J C Lagier; F Armougom; C Robert; I Hamad; P Brouqui; D Raoult
Journal: Eur J Clin Microbiol Infect Dis Date: 2013-01-06 Impact factor: 3.267

4. Modulation of potential respiratory pathogens by pH1N1 viral infection.

Authors: R K-K Leung; J-W Zhou; W Guan; S-K Li; Z-F Yang; S K-W Tsui
Journal: Clin Microbiol Infect Date: 2012-11-20 Impact factor: 8.067

5. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.

Authors: Alicia Marin; Judith Garcia-Aymerich; Jaume Sauleda; Jose Belda; Laura Millares; Marian García-Núñez; Ignasi Serra; Marta Benet; Alvar Agustí; Josep M Antó; Eduard Monsó
Journal: COPD Date: 2012-04 Impact factor: 2.409

6. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability.

Authors: L M Filkins; T H Hampton; A H Gifford; M J Gross; D A Hogan; M L Sogin; H G Morrison; B J Paster; G A O'Toole
Journal: J Bacteriol Date: 2012-06-29 Impact factor: 3.490

7. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America.

Authors: Alexander L Greninger; Eunice C Chen; Taylor Sittler; Alex Scheinerman; Nareg Roubinian; Guixia Yu; Edward Kim; Dylan R Pillai; Cyril Guyard; Tony Mazzulli; Pavel Isa; Carlos F Arias; John Hackett; Gerald Schochetman; Steve Miller; Patrick Tang; Charles Y Chiu
Journal: PLoS One Date: 2010-10-18 Impact factor: 3.240

Review 8. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors: Issar Smith
Journal: Clin Microbiol Rev Date: 2003-07 Impact factor: 26.132

9. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing.

Authors: Man Kit Cheung; Wai Yip Lam; Wendy Yin Wan Fung; Patrick Tik Wan Law; Chun Hang Au; Wenyan Nong; Kai Man Kam; Hoi Shan Kwan; Stephen Kwok Wing Tsui
Journal: PLoS One Date: 2013-01-24 Impact factor: 3.240

10. Eliminating latent tuberculosis.

Authors: Douglas B Young; Hannah P Gideon; Robert J Wilkinson
Journal: Trends Microbiol Date: 2009-04-16 Impact factor: 17.079

11 in total

1. Association Between the Respiratory Microbiome and Susceptibility to Influenza Virus Infection.

Authors: Tim K Tsang; Kyu Han Lee; Betsy Foxman; Angel Balmaseda; Lionel Gresh; Nery Sanchez; Sergio Ojeda; Roger Lopez; Yang Yang; Guillermina Kuan; Aubree Gordon
Journal: Clin Infect Dis Date: 2020-08-22 Impact factor: 9.079

2. The lung microbiome in HIV-positive patients with active pulmonary tuberculosis.

Authors: Veronica Ueckermann; Pedro Lebre; Janri Geldenhuys; Ebrahim Hoosien; Don Cowan; Luricke Janse van Rensburg; Marthie Ehlers
Journal: Sci Rep Date: 2022-05-28 Impact factor: 4.996

Review 3. The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.

Authors: Alexander J Adami; Jorge L Cervantes
Journal: Tuberculosis (Edinb) Date: 2015-07-30 Impact factor: 3.131

4. Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer.

Authors: Urszula Kosikowska; Anna Biernasiuk; Paweł Rybojad; Renata Łoś; Anna Malm
Journal: BMC Microbiol Date: 2016-04-06 Impact factor: 3.605

Review 5. Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker.

Authors: Domenico Maurizio Toraldo; Luana Conte
Journal: J Clin Med Res Date: 2019-10-04

10. Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis.

Authors: Urszula Kosikowska; Paweł Rybojad; Dagmara Stępień-Pyśniak; Anna Żbikowska; Anna Malm
Journal: BMC Infect Dis Date: 2016-08-26 Impact factor: 3.090